By DoM Communications | Date published: November 17, 2025
Kriti Mittal Serves as Lead Author in JACC: CardioOncology Publication
Kriti Mittal, MD, assistant professor of medicine in the Division of Hematology/Oncology, recently served as lead author of an invited editorial in JACC: CardioOncology, where she highlighted a growing and under-recognized challenge in kidney cancer survivorship: the rising burden of cardiovascular disease among patients living longer with renal cell carcinoma (RCC). In her editorial, Dr. Mittal synthesizes evolving evidence at the intersection of oncology and cardiology and calls for a new survivorship framework that integrates cardiovascular risk assessment into routine RCC care.
Drawing on contemporary data and clinical insights, Dr. Mittal underscores the need for improved risk prediction models, better recognition of competing causes of mortality, and the development of integrated care pathways involving oncology, cardiology, and primary care teams. Her work emphasizes how shifts in the RCC treatment landscape, including durable responses to modern immunotherapies and targeted therapies, make cardiovascular health a crucial component of long-term outcomes.
Dr. Mittal’s editorial highlights both the scientific opportunity and the clinical responsibility to redefine survivorship beyond cancer control alone, advocating for team-based, prevention-focused approaches that support the whole patient.